Page last updated: 2024-10-31

milrinone and Obesity

milrinone has been researched along with Obesity in 1 studies

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parker, JC1
VanVolkenburg, MA1
Nardone, NA1
Hargrove, DM1
Andrews, KM1

Other Studies

1 other study available for milrinone and Obesity

ArticleYear
Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III.
    Biochemical and biophysical research communications, 1997, Jul-30, Volume: 236, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipocytes; Animals; Blood Glucose; Glucose Tolerance Test; Gly

1997